PillHydrocortisone Sodium Succinate
Hydrocortisone Sodium Succinate
3 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it3 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Zydus Lifesciences Limited | unknown | 1 | SUPPLYING |
| Zydus Pharmaceuticals USA Inc. | unknown | 1 | SUPPLYING |
| Cipla USA Inc. | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Feb 24, 2026RESOLVEDShortage resolved: Hydrocortisone Sodium Succinate Injection (Cipla Limited)
Hydrocortisone Sodium Succinate Injection — reported in shortage by Cipla Limited. Therapeutic category: Dermatology, Endocrinology/Metabolism, Gastroenterology, Hematology, Neurology, Oncology, Ophthalmology, Pediatric, Pulmonary/Allergy, Renal, Rheumatology.
- Mar 24, 2023SHORTAGEDrug shortage: Hydrocortisone Sodium Succinate Injection (Cipla Limited)
Hydrocortisone Sodium Succinate Injection — reported in shortage by Cipla Limited. Therapeutic category: Dermatology, Endocrinology/Metabolism, Gastroenterology, Hematology, Neurology, Oncology, Ophthalmology, Pediatric, Pulmonary/Allergy, Renal, Rheumatology.